EE200200242A - Meetod suhkurtõve raviks - Google Patents

Meetod suhkurtõve raviks

Info

Publication number
EE200200242A
EE200200242A EEP200200242A EEP200200242A EE200200242A EE 200200242 A EE200200242 A EE 200200242A EE P200200242 A EEP200200242 A EE P200200242A EE P200200242 A EEP200200242 A EE P200200242A EE 200200242 A EE200200242 A EE 200200242A
Authority
EE
Estonia
Prior art keywords
treating diabetes
diabetes
treating
Prior art date
Application number
EEP200200242A
Other languages
English (en)
Inventor
Anne Piper Beth
Original Assignee
Bristol-Myers Squibb Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/432,465 external-priority patent/US6586438B2/en
Application filed by Bristol-Myers Squibb Company filed Critical Bristol-Myers Squibb Company
Publication of EE200200242A publication Critical patent/EE200200242A/et
Publication of EE05260B1 publication Critical patent/EE05260B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
EEP200200242A 1999-11-03 2000-10-13 Metformiini ja glburiidi kombinatsiooni v„ikese annuse kasutamine 2. tpi suhkrut?ve esimese rea raviks EE05260B1 (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/432,465 US6586438B2 (en) 1999-11-03 1999-11-03 Antidiabetic formulation and method
US09/460,920 US7598262B2 (en) 1999-11-03 1999-12-14 Method for treating diabetes
PCT/US2000/028311 WO2001032157A2 (en) 1999-11-03 2000-10-13 Pharmaceutical composition comprising a combination of metformin and glibenclamide

Publications (2)

Publication Number Publication Date
EE200200242A true EE200200242A (et) 2003-12-15
EE05260B1 EE05260B1 (et) 2010-02-15

Family

ID=27029501

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200242A EE05260B1 (et) 1999-11-03 2000-10-13 Metformiini ja glburiidi kombinatsiooni v„ikese annuse kasutamine 2. tpi suhkrut?ve esimese rea raviks

Country Status (23)

Country Link
EP (1) EP1229918B1 (et)
JP (1) JP5183844B2 (et)
KR (1) KR20070089259A (et)
CN (1) CN1450902A (et)
AR (1) AR026356A1 (et)
AT (1) ATE390140T1 (et)
AU (1) AU780106B2 (et)
BR (1) BR0015294A (et)
CA (1) CA2389928C (et)
EE (1) EE05260B1 (et)
HU (1) HU229352B1 (et)
IL (1) IL149139A0 (et)
LT (1) LT5058B (et)
LV (1) LV12910B (et)
MX (1) MXPA02004282A (et)
NO (1) NO330026B1 (et)
NZ (1) NZ518278A (et)
PL (1) PL199278B1 (et)
RU (1) RU2275915C2 (et)
SK (1) SK287810B6 (et)
TW (1) TWI280125B (et)
UY (1) UY26424A1 (et)
WO (1) WO2001032157A2 (et)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2816840B1 (fr) 2000-11-17 2004-04-09 Flamel Tech Sa Medicament a base de microcapsules d'anti-hyperclycemiant a liberation prolongee et son procede de preparation
FR2825023B1 (fr) * 2001-05-23 2005-04-15 Flamel Tech Sa Forme pharmaceutique orale antidiabetique "une prise par jour"comprenant une biguanide et au moins un autre principe actif
WO2003011273A1 (en) * 2001-07-31 2003-02-13 The Governement Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Metformin in the treatment of hyperglycemic conditions
ATE419840T1 (de) 2002-04-09 2009-01-15 Flamel Tech Sa Orale wässrige suspension, mikrokapseln enthaltend, zur kontrollierten freisetzung von wirkstoffen
AU2002356419A1 (en) 2002-06-17 2003-12-31 Themis Laboratories Private Limited Multilayer tablets containing thiazolidinedione and biguanides and methods for producing them
EP1680115A1 (en) * 2003-10-30 2006-07-19 Tioga Pharmaceuticals, Inc. Use of selective opiate receptor modulators in the treatment of neuropathy
AR047779A1 (es) 2003-12-19 2006-02-22 Omega Bio Pharma Ip3 Ltd Composiciones y metodos para tratar diabetes
EP1744737A2 (en) * 2004-05-03 2007-01-24 Omega Bio-Pharma (I.P.3) Limited Cysteamines for treating complications of hypercholesterolemia and diabetes
KR101536786B1 (ko) 2007-07-19 2015-07-14 다케다 야쿠힌 고교 가부시키가이샤 알로그립틴 및 메트포르민 히드로클로라이드를 포함하는 고체 제제
CA2699285C (en) 2007-09-10 2016-12-13 Ahmed F. Abdel-Magid Process for the preparation of compounds useful as inhibitors of sodium-dependent glucose transporter (sglt)
US9056850B2 (en) 2008-10-17 2015-06-16 Janssen Pharmaceutica N.V. Process for the preparation of compounds useful as inhibitors of SGLT
PT2349324T (pt) 2008-10-17 2017-12-06 Sanofi Aventis Deutschland Combinação de uma insulina e de um agonista do glp-1
US20110009347A1 (en) 2009-07-08 2011-01-13 Yin Liang Combination therapy for the treatment of diabetes
EP2498801B1 (de) 2009-11-13 2018-01-24 Sanofi-Aventis Deutschland GmbH HARMAZEUTISCHE ZUSAMMENSETZUNG UMFASSEND desPro36Exendin-4(1-39)-Lys6-NH2 UND METHIONIN
PL2498802T3 (pl) 2009-11-13 2015-06-30 Sanofi Aventis Deutschland Kompozycja farmaceutyczna zawierająca agonistę GLP-1, insulinę i metioninę
JP6227406B2 (ja) 2010-05-11 2017-11-08 ヤンセン ファーマシューティカ エヌ．ベー． ＳＧＬＴの阻害剤としての１−（β−Ｄ−グルコピラノシル）−２−チエニル−メチルベンゼン誘導体を含有する医薬製剤
EP2611458B1 (en) 2010-08-30 2016-09-21 Sanofi-Aventis Deutschland GmbH Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2
WO2012104342A1 (en) * 2011-02-02 2012-08-09 Sanofi-Aventis Deutschland Gmbh Prevention of hypoglycaemia in diabetes mellitus type 2 patients
US20120277147A1 (en) * 2011-03-29 2012-11-01 Sanofi-Aventis Deutschland Gmbh Prevention of hypoglycaemia in diabetes mellitus type 2 patients
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
AR087744A1 (es) 2011-09-01 2014-04-16 Sanofi Aventis Deutschland Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
EP3229828B1 (en) 2014-12-12 2023-04-05 Sanofi-Aventis Deutschland GmbH Insulin glargine/lixisenatide fixed ratio formulation
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
US20170071970A1 (en) 2015-09-15 2017-03-16 Janssen Pharmaceutica Nv Co-therapy comprising canagliflozin and phentermine for the treatment of obesity and obesity related disorders
CN110804017A (zh) * 2019-10-31 2020-02-18 天津大学 磺酰脲化合物与二甲双胍成盐、制备方法和应用
CN113143940A (zh) * 2020-12-30 2021-07-23 成都恒瑞制药有限公司 一种抗糖尿病药物组合物的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3174901A (en) 1963-01-31 1965-03-23 Jan Marcel Didier Aron Samuel Process for the oral treatment of diabetes
DE3833439A1 (de) * 1988-10-01 1991-09-12 Hoechst Ag Verfahren zur mikronisierung von glibenclamid
DK36392D0 (da) 1992-03-19 1992-03-19 Novo Nordisk As Anvendelse af kemisk forbindelse
TWI238064B (en) 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
IT1276130B1 (it) * 1995-11-14 1997-10-27 Gentili Ist Spa Associazione glibenclamide-metformina, composizioni farmaceutiche che la contengono e loro uso nel trattamento del diabete mellito di tipo
ES2284212T3 (es) 1997-06-18 2007-11-01 Smithkline Beecham Plc Tratamiento de diabetes con tiazolidinadiona y metformina.
DE69822505T2 (de) * 1997-12-08 2005-01-20 Bristol-Myers Squibb Co. Neue metformin-salze und verfahren
PT974356E (pt) * 1998-07-15 2004-02-27 Merck Sante Sas Comprimidos compreendendo uma combinacao de metformina e de glibenclamida
EP2620443A1 (en) 2012-01-25 2013-07-31 Galecto Biotech AB Novel galactoside inhibitors of galectins

Also Published As

Publication number Publication date
JP2003519621A (ja) 2003-06-24
LT5058B (lt) 2003-09-25
WO2001032157A3 (en) 2002-01-24
SK5002002A3 (en) 2004-05-04
PL364885A1 (en) 2004-12-27
CN1450902A (zh) 2003-10-22
WO2001032157A2 (en) 2001-05-10
IL149139A0 (en) 2002-11-10
ATE390140T1 (de) 2008-04-15
RU2275915C2 (ru) 2006-05-10
HUP0300218A3 (en) 2006-02-28
EE05260B1 (et) 2010-02-15
LT2002063A (en) 2003-06-25
NO20022087D0 (no) 2002-05-02
CA2389928C (en) 2010-03-23
LV12910B (en) 2003-05-20
BR0015294A (pt) 2003-07-15
CA2389928A1 (en) 2001-05-10
JP5183844B2 (ja) 2013-04-17
AR026356A1 (es) 2003-02-05
NZ518278A (en) 2004-10-29
SK287810B6 (sk) 2011-10-04
MXPA02004282A (es) 2003-02-17
UY26424A1 (es) 2001-05-31
HUP0300218A2 (hu) 2003-06-28
EP1229918A2 (en) 2002-08-14
NO330026B1 (no) 2011-02-07
PL199278B1 (pl) 2008-09-30
KR20070089259A (ko) 2007-08-30
EP1229918B1 (en) 2008-03-26
TWI280125B (en) 2007-05-01
RU2002114820A (ru) 2004-03-10
AU780106B2 (en) 2005-03-03
HU229352B1 (en) 2013-11-28
NO20022087L (no) 2002-06-24
AU1082601A (en) 2001-05-14

Similar Documents

Publication Publication Date Title
EE200200242A (et) Meetod suhkurtõve raviks
FI20000863A0 (fi) Uusi hoitomenetelmä
ID30339A (id) Metode pengobatan baru
ID30025A (id) Metode perlakuan tekstil
DE60028849D1 (de) Sterilisationsmethode
ID25682A (id) Metode untuk melelehkan kaca
DE60030210D1 (de) Elektrolytisches Behandlungsverfahren
EA199900124A3 (ru) Способ лечениясердечной недостаточности
NO331109B1 (no) Fremgangsmate for a utvide et rorformet element i en bronn
DE29905172U1 (de) Handprogrammer
NO20010953L (no) En fremgangsmåte for behandling av stafylokokkal sykdom
NO20001089D0 (no) Mønstergjenkjenningsmetode
NO20013337D0 (no) Ny behandling
DE50005753D1 (de) Montageverfahren
FI20012516A (fi) Päänviennin menetelmä
FI19992786A (fi) Menetelmä ohjelmamoduulin lataamiseksi
NO20006383L (no) Fremgangsmåte for behandling
FI990127A0 (fi) Menetelmä massan käsittelemiseksi
EE200200350A (et) Ühend ja meetod valu raviks
DE69936533D1 (de) Neue behandlungsmethode
UA34041A (uk) Спосіб лікування цукрового діабету
ID26641A (id) Metoda pengobatan
SE9802791D0 (sv) Behandlingsmetod
UA33970A (uk) Спосіб лікування періодонтиту
FI990172A0 (fi) Marvi-menetelmä

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20101231